January 19th 2022
Claire Harrison, MD, FRCP, FRCPath, discusses current unmet needs in myelofibrosis.
December 1st 2021
Claire Harrison, MD, FRCP, FRCPath, discusses the current state of treatment in myelofibrosis.
December 6th 2015
Claire Harrison, MD, deputy clinical director of Cancer and Hematology, Guy's and St. Thomas' NHS, discusses 5-year follow-up data examining ruxolitinib in patients with myelofibrosis.